An open-label, pilot trial evaluating the efficacy, safety and tolerability of desvenlafaxine monotherapy in patients with persistent depressive disorder.
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2016
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Depressive disorders
- Focus Adverse reactions; Therapeutic Use
- 08 Oct 2016 New trial record